Homo sapiens Protein: GNA11 | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||||||
InnateDB Protein | IDBP-16832.6 | ||||||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||||||
Gene Symbol | GNA11 | ||||||||||||||||||||||||||
Protein Name | guanine nucleotide binding protein (G protein), alpha 11 (Gq class) | ||||||||||||||||||||||||||
Synonyms | FBH; FBH2; FHH2; GNA-11; HHC2; HYPOC2; | ||||||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||||||
Ensembl Protein | ENSP00000078429 | ||||||||||||||||||||||||||
InnateDB Gene | IDBG-16830 (GNA11) | ||||||||||||||||||||||||||
Protein Structure |
![]() |
||||||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||||||
Function | Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. Acts as an activator of phospholipase C. | ||||||||||||||||||||||||||
Subcellular Localization | Cell membrane {ECO:0000305PubMed:18703424}; Lipid-anchor {ECO:0000305PubMed:18703424}. Cytoplasm {ECO:0000269PubMed:18703424}. Note=In testicular cells, expressed exclusively in the cytoplasm. | ||||||||||||||||||||||||||
Disease Associations | Hypocalciuric hypercalcemia, familial 2 (HHC2) [MIM:145981]: A form of hypocalciuric hypercalcemia, a disorder of mineral homeostasis that is transmitted as an autosomal dominant trait with a high degree of penetrance. It is characterized biochemically by lifelong elevation of serum calcium concentrations and is associated with inappropriately low urinary calcium excretion and a normal or mildly elevated circulating parathyroid hormone level. Hypermagnesemia is typically present. Affected individuals are usually asymptomatic and the disorder is considered benign. However, chondrocalcinosis and pancreatitis occur in some adults. {ECO:0000269PubMed:23802516}. Note=The disease is caused by mutations affecting the gene represented in this entry.Hypocalcemia, autosomal dominant 2 (HYPOC2) [MIM:615361]: A form of hypocalcemia, a disorder of mineral homeostasis characterized by blood calcium levels below normal, and low or normal serum parathyroid hormone concentrations. Disease manifestations include hypocalcemia, paresthesias, carpopedal spasm, seizures, hypercalciuria with nephrocalcinosis or kidney stones, and ectopic and basal ganglia calcifications. {ECO:0000269PubMed:23782177, ECO:0000269PubMed:23802516}. Note=The disease is caused by mutations affecting the gene represented in this entry. | ||||||||||||||||||||||||||
Tissue Specificity | Expressed in testis. {ECO:0000269PubMed:18703424}. | ||||||||||||||||||||||||||
Comments | |||||||||||||||||||||||||||
Interactions | |||||||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 19 experimentally validated interaction(s) in this database.
They are also associated with 1 interaction(s) predicted by orthology.
|
||||||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||||||
InterPro |
IPR000654
G-protein alpha subunit, group Q IPR001019 Guanine nucleotide binding protein (G-protein), alpha subunit IPR002975 Fungal G-protein, alpha subunit IPR006689 Small GTPase superfamily, ARF/SAR type IPR011025 G protein alpha subunit, helical insertion IPR027417 P-loop containing nucleoside triphosphate hydrolase |
||||||||||||||||||||||||||
PFAM |
PF00503
PF00025 |
||||||||||||||||||||||||||
PRINTS |
PR00442
PR00318 PR01241 PR00328 |
||||||||||||||||||||||||||
PIRSF | |||||||||||||||||||||||||||
SMART |
SM00275
|
||||||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||||||
Modification | |||||||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||||||
SwissProt | P29992 | ||||||||||||||||||||||||||
PhosphoSite | PhosphoSite-P29992 | ||||||||||||||||||||||||||
TrEMBL | Q59FM5 | ||||||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||||||
Entrez Gene | 2767 | ||||||||||||||||||||||||||
UniGene | Hs.732269 | ||||||||||||||||||||||||||
RefSeq | NP_002058 | ||||||||||||||||||||||||||
HUGO | HGNC:4379 | ||||||||||||||||||||||||||
OMIM | 139313 | ||||||||||||||||||||||||||
CCDS | CCDS12103 | ||||||||||||||||||||||||||
HPRD | 00759 | ||||||||||||||||||||||||||
IMGT | |||||||||||||||||||||||||||
EMBL | AB209435 AC005262 AF011497 AF493900 BC089041 BC096225 BC096226 BC096227 CR457004 L40630 M69013 | ||||||||||||||||||||||||||
GenPept | AAA58624 AAA99949 AAB64303 AAC25615 AAH89041 AAH96225 AAH96226 AAH96227 AAM12614 BAD92672 CAG33285 | ||||||||||||||||||||||||||